what is a microdose glp-1 Microdosing of GLP-1's / Wellness Services / Services Is It Safe to Microdose
Description
This letter gives some concrete, documented evidence of the patient safety risks that critics of compounding have been warning about

Lixisenatide: Gastrointestinal : acute pancreatitis, hemorrhagic and necrotizing pancreatitis, ileus, intestinal obstruction, severe constipation including fecal impaction Hepatobiliary: cholecystitis, cholelithiasis requiring cholecystectomy Neurologic: dysgeusia, dysesthesia Pulmonary: pulmonary aspiration has occurred in patients receiving GLP-1 receptor agonists under-going elective surgeries or procedures requiring general anesthesia or deep sedation

cakes and biscuits, sweets, chocolates, fruit juice and smoothies, jam, marmalade and honey
The rapid increase in the use of these medications has led to supply challenges and resulted in the proliferation of compounded analogs, raising concerns about safety and bioequivalence [45]

Body-mass index and incidence of cancer

If weight loss is within 80% of the expected rate for your dose, microdosing may be working adequately